Issue 56, 2014

The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells

Abstract

Asplatin, a fusion of aspirin and cisplatin, exhibits significant cytotoxicity in tumor cells and almost fully overcomes the drug resistance of cisplatin resistant cells. Asplatin is highly accumulated in cancer cells and is activated upon the reduction by ascorbic acid.

Graphical abstract: The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells

Supplementary files

Article information

Article type
Communication
Submitted
17 Jan 2014
Accepted
27 Feb 2014
First published
28 Feb 2014

Chem. Commun., 2014,50, 7427-7430

Author version available

The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells

Q. Cheng, H. Shi, H. Wang, Y. Min, J. Wang and Y. Liu, Chem. Commun., 2014, 50, 7427 DOI: 10.1039/C4CC00419A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements